RAPT

Rapt Therapeutics Stock Analysis

AI Rating

Good
  • Quality0/10
  • Growth↑ 7/10
  • Momentum↑ 9/10
Rapt Therapeutics sales and earnings growth
RAPT Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 47.76%
  • FCF Y/Y↑ 14.03%
Rapt Therapeutics gross and profit margin trends
RAPT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -107.60%
Rapt Therapeutics net debt vs free cash flow
RAPT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Rapt Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗